StevenEKempersMD

Dermatology • New Brighton, MN

Physician

Join to view full profile

Dr. Kempers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kempers' full profile

Already have an account?

Office
119 14th Street NW, Suite 250
New Brighton, MN 55112
Phone+1 763-571-4200

Fax+1 763-571-7202
Is this information wrong?

Education & Training

University of MinnesotaResidency, Dermatology, 1986 - 1989
Santa Barbara Cottage HospitalInternship, Internal Medicine, 1985 - 1986
Perelman School of Medicine at the University of PennsylvaniaClass of 1985

Certifications & Licensure

CA State Medical License 1986 - 2026
MN State Medical License 1986 - 2024
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Clinical Trials

A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis Start of enrollment: 2007 May 07
Completed
Phase 2
Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris Start of enrollment: 2007 Feb 01
Completed
Phase 3
Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail Start of enrollment: 2007 Jan 01
Completed
Phase 2
Epiduo Pediatric Acne Study Start of enrollment: 2010 Jun 01
Completed
Phase 4
Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2010 Aug 01
Completed
Phase 2
Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2011 Mar 01
Completed
Phase 3
Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail Start of enrollment: 2011 Jul 01
Completed
Phase 2
Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis Start of enrollment: 2013 Mar 01
Completed
Phase 2
VPD-737 for Treatment of Chronic Pruritus Start of enrollment: 2013 Oct 15
Completed
Phase 2
Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities Start of enrollment: 2014 May 01
Completed
Phase 3
Twelve Month Follow-Up of CP0108 Start of enrollment: 2014 Aug 01
Completed
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Start of enrollment: 2015 Apr 01
Completed
Phase 2
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Dec 01
Completed
Phase 3
Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face Start of enrollment: 2016 Mar 01
Completed
Phase 2
Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat Start of enrollment: 2016 Dec 22
Completed
Phase 2
Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp Start of enrollment: 2017 Mar 01
Withdrawn
Phase 3
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Recruiting
Phase 3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: a 52-week, phase 2, open-label trial.
Linda Stein Gold, David N Adam, Lorne Albrecht, Javier Alonso-Llamazares, Laura K Ferris, Melinda J Gooderham, H Chih-Ho Hong, Steven E Kempers, Leon H Kircik, Mark Le...> ;Journal of the American Academy of Dermatology. 2024 Mar 29
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Leon H Kircik, Javier Alonso-Llamazares, Neal Bhatia, Michael Bukhalo, Alim R Devani, Zoe D Draelos, Janet DuBois, Melinda J Gooderham, Steven E Kempers, Edward Lain, ...> ;The British Journal of Dermatology. 2023 Sep 15
1 citations
Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the ...
Kalyani Marathe, Joyce M C Teng, Scott Guenthner, Christopher G Bunick, Steven Kempers, Kimmie Eads, Leslie Castelo-Soccio, Alan M Mendelsohn, Jessica Raiz, Dédée F Mu...> ;Dermatology and Therapy. 2023 Jun 1
2 citations
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
Matthew J Zirwas, Zoe D Draelos, Janet DuBois, Leon H Kircik, Angela Y Moore, Linda Stein Gold, Javier Alonso-Llamazares, Michael Bukhalo, Suzanne Bruce, Kimmie Eads, ...> ;JAMA Dermatology. 2023 Jun 1
Characteristics and outcomes for participants with congenital ichthyosis who responded to treatment with the topical isotretinoin formulation TMB-001: results from the...
Christopher G Bunick, Joyce M C Teng, Scott Guenthner, Kalyani Marathe, Steven Kempers, Kimmie Eads, Leslie Castelo-Soccio, Alan M Mendelsohn, Jessica Raiz, Dédée F Mu...> ;Clinical and Experimental Dermatology. 2023 Jul 7
1 citations
Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked...
Dedee F Murrell, Joyce M C Teng, Scott Guenthner, Kalyani Marathe, Steven Kempers, Kimmie Eads, Leslie Castelo-Soccio, Alan M Mendelsohn, Jessica Raiz, Christopher G B...> ;Clinical and Experimental Dermatology. 2023 Jun 5
2 citations
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial.
Linda Stein Gold, Javier Alonso-Llamazares, Zoe D Draelos, Melinda J Gooderham, Steven E Kempers, Leon H Kircik, Mark G Lebwohl, Kim A Papp, David M Pariser, Darryl P ...> ;American Journal of Clinical Dermatology. 2023 Mar 1
31 citations
Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata.
Brett King, Natasha Mesinkovska, Paradi Mirmirani, Suzanne Bruce, Steve Kempers, Emma Guttman-Yassky, Janet L Roberts, Amy McMichael, Maria Colavincenzo, Colleen Hamil...> ;Journal of the American Academy of Dermatology. 2022 Aug 1
3 citations
The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linke...
Joyce M C Teng, Christopher G Bunick, Scott Guenthner, Dedee F Murrell, Kalyani Marathe, Steven Kempers, Kimmie Eads, Alan M Mendelsohn, Jessica Raiz, Amir Tavakkol, L...> ;Journal of the American Academy of Dermatology. 2022 Dec 1
3 citations
Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial
Janet DuBois, Suzanne Bruce, Daniel Stewart, Steven Kempers, Christy Harutunian, Terry Boodhoo, Amy Weitzenfeld, Joan-En Chang-Lin> ;Clinical, Cosmetic and Investigational Dermatology. 2021 Oct 15
48 citations
Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
Andrew Blauvelt, Steven Kempers, Edward Lain, Todd Schlesinger, Stephen K. Tyring, Seth Forman, Glynis Ablon, George R. Martin, Hui Wang, David Lawrence Cutler, Jane F...> ;The New England Journal of Medicine. 2021 Feb 10
47 citations
Trial of Roflumilast Cream for Chronic Plaque Psoriasis
Mark Lebwohl, Kim A. Papp, Linda Stein Gold, Melinda Gooderham, Leon H Kircik, Zoe Diana Draelos, Steven Kempers, Mathew Zirwas, Kathleen Smith, David Osborne, Marie-L...> ;The New England Journal of Medicine. 2020 Jul 15
5 citations
Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, doubl...
Aditya K. Gupta, Maria S. Surprenant, Steven Kempers, David M. Pariser, Kjell Rensfeldt, Amir Tavakkol> ;Journal of the American Academy of Dermatology. 2021 Jul 1
10 citations
A Randomized, Vehicle-Controlled Phase 3 Study of Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses on the Upper Extremities
Shang I Brian Jiang, Steven Kempers, Phoebe Rich, Stuart Marcus, Anna Houlihan, Daniel Piacquadio, David M. Pariser> ;Dermatologic Surgery. 2019 Jul 1
23 citations
Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placeb...
Leslie Baumann, Andrew Blauvelt, Zoe Diana Draelos, Steven Kempers, Mary P. Lupo, Joel Schlessinger, Stacy Smith, David Wilson, Mark Bradshaw, Esther Estes, Stuart D. ...> ;Journal of the American Academy of Dermatology. 2018 Nov 1
51 citations
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind C...
Angela Yen Moore, Lawrence Green, Suzanne Bruce, Neil S. Sadick, Eduardo Tschen, Philip Werschler, Fran E Cook-Bolden, Sunil Dhawan, Douglass W. Forsha, Michael H. Gol...> ;Journal of Drugs in Dermatology. 2018 Sep 1
30 citations
Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial
Zoe Diana Draelos, Michael H. Gold, Robert Weiss, Leslie Baumann, Steven Grekin, Deanne Mraz Robinson, Steven Kempers, Nancy Alvandi, Emily Weng, David R. Berk, Gurpre...> ;Journal of the American Academy of Dermatology. 2018 Jun 1
4 citations
Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu.
Zoe Diana Draelos, David Rodriguez, Steven Kempers, Suzanne Bruce, Marina I Peredo, Jeanine Downie, Joan-En Chang-Lin, David R. Berk, Shiling Ruan, Alexandre Kaoukhov> ;Journal of Drugs in Dermatology. 2017 Jun 1
5 citations
An open-label, multicenter study of the efficacy and safety of a weekday/weekend treatment regimen with calcitriol ointment 3 microg/g and clobetasol propionate spray ...
Charles P Hudson, Steven Kempers, Alan Menter, Kim A. Papp, Stacy Smith, Howard Sofen, Luz E Colón, Lori A Johnson, Ronald W Gottschalk> ;Cutis. 2011 Oct 1
3 citations
An open-label, multicenter study of the efficacy and safety of an AM/PM treatment regimen with clobetasol propionate spray 0.05% and calcitriol ointment 3 microg/g in ...
Alan Menter, Howard Sofen, Stacy Smith, Kim A. Papp, Steven Kempers, Charles P Hudson, Luz E Colón, Lori A Johnson, Ronald W Gottschalk> ;Cutis. 2011 Jul 1
6 citations
Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening ...
David M. Pariser, Alicia D. Bucko, Richard G. Fried, Michael Jarratt, Steven Kempers, Leon H Kircik, Anne W. Lucky, Elyse S. Rafal, Marta I. Rendon, Jonathan S. Weiss,...> ;Journal of Drugs in Dermatology. 2010 Jul 1
10 citations
Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lawrence F. Eichenfield, Michael Jarratt, Joel Schlessinger, Steven Kempers, Manna, Joyce Hwa, Yin Liu, Michael Graeber> ;Journal of Drugs in Dermatology. 2010 Jun 1
12 citations
Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects.
Robert Matheson, Steven Kempers, Debra L. Breneman, Zoe Diana Draelos, Candice E Johnson, Robert Loss, Daniel J Hogan, Robert J. Schoenfeld, Scott Checketts, Leon H Ki...> ;Journal of Drugs in Dermatology. 2008 Mar 1
14 citations
Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic derma...
William Abramovits, Adelaide A. Hebert, Mark Boguniewicz, Steven Kempers, Eduardo Tschen, Michael Jarratt, Anne W. Lucky, Raymond L. Cornelison, Leonard J. Swinyer, Te...> ;The Journal of Dermatological Treatment. 2008 Jan 1
23 citations
A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions
Boni E. Elewski, William Abramovits, Steven Kempers, Joel Schlessinger, Theodore Rosen, Aditya K. Gupta, Sabra Abraham, Richard Rowell> ;Journal of Drugs in Dermatology. 2007 Oct 1
Join now to see all

Journal Articles

Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis
Andrew Blauvelt, Steven Kempers, Stephen Tyring, Glynis Ablon, The New England Journal of Medicine
Trial of Roflumilast Cream for Chronic Plaque Psoriasis
Leon H Kircik, Steven E Kempers, Howard Welgus, The New England Journal of Medicine